Australian Broker Call *Extra* Edition – Jul 29, 2024

This story features 29METALS LIMITED, and other companies. For more info SHARE ANALYSIS: 29M

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

29M   AGY   ATA   CVN   EVN   GNE   LNW   NWC   NWL   PRN   PSC   SDV   SFR   TLX   WES  

29M    29METALS LIMITED

Copper – Overnight Price: $0.38

Canaccord Genuity rates ((29M)) as Downgrade to Sell from Hold (5) –

29Metals’ June-quarter result disappointed Canaccord Genuity despite an operational improvement at Golden Grove and a decent production beat on all metals save zinc and a consensus beat on costs (albeit a miss for the broker).

The big problem in the broker’s view was a failure to capitalise on strong base metals pricing with cash flow missing both consensus and Canaccord Genuity’s forecasts and a net draw-down of -US$10m in debt.

The company closed the quarter with net debt of $146m, up from $106m, and advised of a $27m stamp duty liability. While the company has sufficient liquidity, the broker observes the balance sheet is more precarious.

The broker forecasts challenging operating conditions due to a lack of consistency at Golden Grove on key financial metrics.

Rating is downgraded to Sell from Hold. Target price slumps to 34c from 44c.

This report was published on July 24, 2024.

Target price is $0.34 Current Price is $0.38 Difference: minus $0.04 (current price is over target).
If 29M meets the Canaccord Genuity target it will return approximately minus 11% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $0.55, suggesting upside of 39.7%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 6.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 6.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -8.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 38.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 13.9.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AGY    ARGOSY MINERALS LIMITED

New Battery Elements – Overnight Price: $0.05

Petra Capital rates ((AGY)) as Downgrade to Hold from Buy (3) –

Argosy Minerals has suspended production at its Rincon lithium carbonate production facility in Argentina due to an inability to meet its nameplate production rates, observes Petra Capital.

The broker observes mechanical issues at the filtering stage have proven the project to be uneconomic given the small production base.

Management now turns its focus to cash conservation and developing its larger plants with better economies of scale.

FY24 EPS forecasts fall. FY25 EPS forecasts rise. Rating is downgraded to Hold from Buy. Target price slumps to 5c from 31c.

This report was published on July 25, 2024.

Target price is $0.05 Current Price is $0.05 Difference: $0.002
If AGY meets the Petra Capital target it will return approximately 4% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 3.69.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 24.00.

Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ATA    ATTURRA LIMITED

Software & Services – Overnight Price: $0.81

Moelis rates ((ATA)) as Initiation of coverage with Buy (1) –

Moelis initiates coverage on IT Services provider Attura, which services the defence, government, utilities, education, financial services and manufacturing sectors.

The broker estimates the company can achieve a roughly 13% EPS compound annual growth rate between FY24 and FY27 due to: increased share of existing client base’s budgets; a growing service offering and new capabilities; and inorganic growth opportunities (it has a strategy of 50:50 organic and inorganic growth).

Buy rating and $1.25 target price.

This report was published on July 25, 2024.

Target price is $1.25 Current Price is $0.81 Difference: $0.44
If ATA meets the Moelis target it will return approximately 54% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of 5.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.58.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.46.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CVN    CARNARVON ENERGY LIMITED

Crude Oil – Overnight Price: $0.17

Jarden rates ((CVN)) as Buy (1) –

Jarden says the final investment decision-ready status for Dorado Phase 1 was widely expected and retains its 2026 FID and 2939 first liquids production forecasts.

Buy rating retained to reflect Carnarvon Energy’s cash backing and the broker’s unrisked Dorado/Pavo valuation. Target price is steady at 24c.

This report was published on July 18, 2024.

Target price is $0.24 Current Price is $0.17 Difference: $0.075
If CVN meets the Jarden target it will return approximately 45% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.00 cents.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.00 cents.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

EVN    EVOLUTION MINING LIMITED

Gold & Silver – Overnight Price: $3.93

Jarden rates ((EVN)) as Underweight (4) –

Evolution Mining’s June-quarter result missed guidance but sentiment was saved by a strong cash build and a 15% rise in Cowal volumes despite poor weather, observes Jarden.

The broker expects high commodity price to boost the balance sheet in FY25, observing headline gearing declined to 25% from 33% in FY24, raising the odds of a 10cps final dividend (possibly 12cps fully franked in FY25).

But costs proved a solid miss on consensus forecasts, and the broker expects the market needs to raise all in sustaining cost forecasts by at least 5%.

Underweight rating retained on valuation and the capital expenditure outlook. Target price rises to $3.19 from $3.15.

This report was published on July 18, 2024.

Target price is $3.19 Current Price is $3.93 Difference: minus $0.74 (current price is over target).
If EVN meets the Jarden target it will return approximately minus 19% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $4.15, suggesting upside of 5.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 12.00 cents and EPS of 18.50 cents.
At the last closing share price the estimated dividend yield is 3.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.24.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 22.5, implying annual growth of 152.5%.
Current consensus DPS estimate is 9.3, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 17.5.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 12.00 cents and EPS of 34.70 cents.
At the last closing share price the estimated dividend yield is 3.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.0, implying annual growth of 86.7%.
Current consensus DPS estimate is 15.5, implying a prospective dividend yield of 3.9%.
Current consensus EPS estimate suggests the PER is 9.4.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

GNE    GENESIS ENERGY LIMITED

Infrastructure & Utilities – Overnight Price: $1.99

Jarden rates ((GNE)) as Overweight (2) –

Jarden reviews its Overweight rating for Genesis Energy given the company’s recent share-price retreat.

The broker argues it will take more than removing the Kupe dividend to level it up with renewable gentailers (the company announced this ambition last year), which are trading at a premium.

The broker suggests Genesis Energy will need to be broken up to unlock the green premium.

The obvious solution would be to spin off the thermal assets, including Huntly, Kup, battery options and gas, says Jarden, placing responsibility for capacity support back onto the industry, and also cleanly dividing the capital expenditure split.

Short of this, the broker expects the company will be less transparent for many years. Overweight rating retained on valuation. Target price rises to NZ$2.78 from NZ$2.60.

This report was published on July 17, 2024.

Current Price is $1.99. Target price not assessed.
The company’s fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 12.93 cents and EPS of 6.09 cents.
At the last closing share price the estimated dividend yield is 6.50%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.66.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 13.30 cents and EPS of 7.76 cents.
At the last closing share price the estimated dividend yield is 6.68%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.66.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

LNW    LIGHT & WONDER INC

Gaming – Overnight Price: $156.73

Jarden rates ((LNW)) as Buy (1) –

Light & Wonder has taken the opportunity to reprice its main US$2.2bn US Term Loan B facility, which results in a cut to 225 basis points over benchmark from 275 basis points (310 basis points in February).

While not big enough to really turn the dial, the broker appreciates management’s proactive approach to the balance sheet. 

EPS forecasts rise 1.2% across FY24 to FY26 to reflect the cuts.

Buy rating retained. Target price rises to $167 from $166. 

This report was published on July 18, 2024.

Target price is $167.00 Current Price is $156.73 Difference: $10.27
If LNW meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $170.00, suggesting upside of 6.3%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 449.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 462.6, implying annual growth of 71.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 34.6.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 598.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.20.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 592.4, implying annual growth of 28.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 27.0.

Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NWC    NEW WORLD RESOURCES LIMITED

Copper – Overnight Price: $0.03

Canaccord Genuity rates ((NWC)) as Speculative Buy (1) –

New World Resources released the pre-feasibility study for the Antler Copper Project which is slightly better than the Canaccord Genuity analyst’s expectations.

The broker highlights a 12.2-year underground mine with production capacity of around 30kt copper equivalent p.a., compared to the analyst’s forecast of 26kt p.a., and capex of -US$298m against the analyst’s expectations of -US$300m.

Speculative Buy. Target 12c.

This report was published on July 17, 2024.

Target price is $0.12 Current Price is $0.03 Difference: $0.093
If NWC meets the Canaccord Genuity target it will return approximately 344% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NWL    NETWEALTH GROUP LIMITED

Wealth Management & Investments – Overnight Price: $22.60

Jarden rates ((NWL)) as Underweight (4) –

Netwealth Group’s June-quarter custodial net flows outpaced consensus’ and Jarden’s forecasts by a decent clip, thanks to an improvement in annualised net inflows as a percentage of funds under adminstration (FUA).

FUA, however, ended up being in line with the broker due to poorer than expected net investment returns.

Given the company posted strong new account growth and expects major early-stage transitions will boost FY25 inflows, the broker raises net-flow and EPS forecasts (1.1% in FY25 and 2.1% in FY26). 

Underweight rating retained. Target price rises to $17.75 from $17.30.

This report was published on July 16, 2024.

Target price is $17.75 Current Price is $22.60 Difference: minus $4.85 (current price is over target).
If NWL meets the Jarden target it will return approximately minus 21% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $20.64, suggesting downside of -10.1%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 30.30 cents and EPS of 34.80 cents.
At the last closing share price the estimated dividend yield is 1.34%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 64.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 33.9, implying annual growth of 23.1%.
Current consensus DPS estimate is 29.6, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 67.7.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 38.70 cents and EPS of 44.40 cents.
At the last closing share price the estimated dividend yield is 1.71%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 50.90.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.4, implying annual growth of 25.1%.
Current consensus DPS estimate is 36.8, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 54.2.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PRN    PERENTI LIMITED

Mining Sector Contracting – Overnight Price: $1.04

Canaccord Genuity rates ((PRN)) as Buy (1) –

Perenti has secured a one year contract extension at the Khoemacau Copper mine in Botswana and a three-year extension at Sunrise Dam worth around $450m, Canaccord Genuity notes.

The broker expects the company will achieve earnings guidance when the FY24 results are announced in August.

Buy rating and $1.25 target retained.

This report was published on July 16, 2024.

Target price is $1.25 Current Price is $1.04 Difference: $0.205
If PRN meets the Canaccord Genuity target it will return approximately 20% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PSC    PROSPECT RESOURCES LIMITED

New Battery Elements – Overnight Price: $0.12

Canaccord Genuity rates ((PSC)) as Speculative Buy (1) –

Canaccord Genuity believes Prospect Resources is on a “new course” post the acquisition of an 85% interest in the Mumbezhi Copper Project in Zambia.

The project is located within the Zambian copper belt with three large adjacent mines.

Price target raised to 30c from 13c. Speculative Buy.

This report was published on July 16, 2024.

Target price is $0.30 Current Price is $0.12 Difference: $0.175
If PSC meets the Canaccord Genuity target it will return approximately 140% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SDV    SCIDEV LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $0.50

Canaccord Genuity rates ((SDV)) as Upgrade to Buy from Speculative Buy (1) –

SciDev’s June-quarter report sharply outpaced Canaccord Genuity’s forecasts leading to a 2% beat on the broker’s FY24 revenue forecasts.

Earnings (EBITDA) proved a miss as did operating cash flow.

Free cash flow proved a strong beat and the company closed June 30 with a cash balance of $9.4m (the broker forecast $6.7m) with no debt, thanks in part to less capital expenditure and reduced earnout, observes the broker.

Canaccord Genuity forecasts a strong September given tender activity and secured pipeline. EPS forecasts rise 5% for FY25.

Rating is upgraded to Buy from Speculative Buy. Target price rises to 68c from 54c.

This report was published on July 25, 2024.

Target price is $0.68 Current Price is $0.50 Difference: $0.18
If SDV meets the Canaccord Genuity target it will return approximately 36% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 1.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 31.25.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 3.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.63.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SFR    SANDFIRE RESOURCES LIMITED

Copper – Overnight Price: $8.26

Wilsons rates ((SFR)) as Upgrade to Overweight from Market Weight (1) –

Sandfire Resources’ June-quarter operations report broadly met revised guidance and consensus forecasts with operating costs nosing out Wilsons’ forecasts.

C1 costs at both Matsa and Motheo proved a sharp beat, the former due to operating costs and the latter to strong silver credits.

Earnings (EBITDA) outpaced thanks to strong sales. 

Rating is upgraded to Overweight from Market Weight to reflect the recent share price retreat. Target price is steady at $9.90.

This report was published on July 26, 2024.

Target price is $9.90 Current Price is $8.26 Difference: $1.64
If SFR meets the Wilsons target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $9.14, suggesting upside of 9.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 8.09 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 102.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -5.8, implying annual growth of N/A.
Current consensus DPS estimate is 1.1, implying a prospective dividend yield of 0.1%.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 41.04 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.13.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 73.0, implying annual growth of N/A.
Current consensus DPS estimate is 19.0, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 11.4.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TLX    TELIX PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $19.32

Jarden rates ((TLX)) as Buy (1) –

Telix Pharmaceuticals’ June-quarter revenue outpaced consensus by 7% but missed Jarden’s forecast by -2.2%.

Management upgraded FY24 revenue guidance 10% at the midpoint, and Jarden considers this to be conservative, given it excludes Illucix sales once EU approval is gained. Management also re-affirmed research and development guidance.

One surprise, says Jarden, was the CMS introduction of a separate Medicare payment code for diagnostic radiopharmaceuticals (previously unbundled payments), sharply reducing the post-June impact (previously a forecast -25% price fall) when the pass-through payment expired.

The final rule is due to be set in November but the broker says it is too early to estimate the final reimbursement from CMS. Jarden plumps for a conservative -2.5% price cut across all Illucix sales from the 2025 December half until greater clarification is received.

The broker upgrades its Illucix total addressable market by 17% and estimates a 4% compound annual growth rate as physicians opt for Illucix as a baseline for follow-up scans.

EPS forecasts fall -3.5% in FY24; -11.4% in FY25; and rise 37.7% in FY26 (to reflect the removal of the -25% price cut arising from the CMS rule).

Buy rating retained. Target price rises to $22.49 from $16.62.

This report was published on July 18, 2024.

Target price is $22.49 Current Price is $19.32 Difference: $3.17
If TLX meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 19.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 100.63.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 33.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 56.99.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WES    WESFARMERS LIMITED

Consumer Products & Services – Overnight Price: $70.92

Jarden rates ((WES)) as Neutral (3) –

Jarden downgrades earnings forecasts for Wesfarmers to reflect weaker commodity prices, slowing housing activity (the broker observes footfall is slowing at Bunnings and emerging deflation) and growing competition in the discretionary retail market from the likes of Amazon and Temu.

But the broker expects the company will outperform its peers due to a cyclic retail recovery, a rising ammonium nitrate market, strong strategic execution in health and stronger momentum, and raises its target price to $60.70 from $58.60.

EPS forecasts fall -1% to -8% across FY24 to FY26. Neutral rating retained on valuation.

This report was published on July 16, 2024.

Target price is $60.70 Current Price is $70.92 Difference: minus $10.22 (current price is over target).
If WES meets the Jarden target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $61.27, suggesting downside of -14.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 204.00 cents and EPS of 229.90 cents.
At the last closing share price the estimated dividend yield is 2.88%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 30.85.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 226.6, implying annual growth of 4.1%.
Current consensus DPS estimate is 193.7, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 31.5.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 230.00 cents and EPS of 245.00 cents.
At the last closing share price the estimated dividend yield is 3.24%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 245.4, implying annual growth of 8.3%.
Current consensus DPS estimate is 210.7, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 29.1.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms